Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 7,410,000 | 6,578,000 | 6,275,000 | 6,354,000 | 6,664,000 |
| Cost of Goods | 1,525,000 | 1,370,000 | 984,000 | 1,420,000 | 1,378,000 |
| Gross Profit | 5,885,000 | 5,208,000 | 5,291,000 | 4,934,000 | 5,286,000 |
| Operating Expenses | 4,398,000 | 4,037,000 | 4,007,000 | 3,714,000 | 4,709,000 |
| Operating Income | 1,487,000 | 1,171,000 | 1,284,000 | 1,220,000 | 577,000 |
| Interest Expense | 321,000 | 324,000 | 329,000 | 332,000 | 351,000 |
| Other Income | 1,000 | 6,000 | 6,000 | 47,000 | 14,000 |
| Pre-tax Income | 1,167,000 | 853,000 | 961,000 | 935,000 | 240,000 |
| Income Tax | 162,000 | 202,000 | 223,000 | 185,000 | -37,000 |
| Net Income Continuous | 1,005,000 | 651,000 | 738,000 | 750,000 | 277,000 |
| Minority Interests | -7,000 | 3,000 | -18,000 | -30,000 | -36,000 |
| Net Income | $1,012,000 | $648,000 | $756,000 | $780,000 | $313,000 |
| EPS Basic Total Ops | 0.39 | 0.25 | 0.29 | 0.30 | 0.12 |
| EPS Basic Continuous Ops | 0.38 | 0.25 | 0.28 | 0.29 | 0.10 |
| EPS Diluted Total Ops | 0.39 | 0.25 | 0.29 | 0.30 | 0.12 |
| EPS Diluted Continuous Ops | 0.38 | 0.25 | 0.28 | 0.29 | 0.10 |
| EBITDA(a) | $2,284,000 | $1,972,000 | $1,994,000 | $2,061,000 | $2,220,000 |